Getting SMART about Adaptive Interventions: A Conceptual Introduction Rona L. Levy With many thanks to Daniel Almirall

Size: px
Start display at page:

Download "Getting SMART about Adaptive Interventions: A Conceptual Introduction Rona L. Levy With many thanks to Daniel Almirall"

Transcription

1 Getting MART about Adaptive Interventions: A Conceptual Introduction Rona L. Levy rlevy@uw.edu With many thanks to Daniel Almirall Institute for ocial Research, University of Michigan

2 Adaptive Interventions Definition: An Adaptive Intervention is a sequence of individually tailored decision rules that specify whether, how, or when and based on which measures to alter the dosage (duration, frequency or amount), type, or delivery of treatment(s) at critical decision points. Adaptive Interventions (AIs) help guide the type of sequential treatment decision making that is typical of (and often needed in!) educational or clinical practice.

3 Concrete Example of an Adaptive Intervention Child ADHD in chools, Ages 6-12 First-line Txt Tailoring Variable econd-line Txt Responder Continue: MED MED Non-Responders Augment: MED + BM Responder status measured by school-teacher. Goal is to min. symptoms / max. school performance.

4 What makes up an Adaptive Intervention? 1. Critical decision points: based on time or other measures 2. Treatment options at each stage 3. Tailoring variables: to decide how to adapt treatment 4. Decision rules: inputs tailoring variable, outputs treatments aka: dynamic treatment regiment, adaptive txt strategies, treatment algorithms, medication algorithms, stepped care, txt policies, multi-stage strategies

5 Why are Adaptive Interventions Necessary? In Clinical Practice... Nature of chronic disorders/phenomena (substance use, obesity, mental health, autism, diabetes, cancer, HIV/AID, pain) Waxing and waning course (multiple relapse, recurrence) Life events, comorbidities, non-adherence may arise Disorders for which there is no widely effective treatment. Disorders for which there are widely effective treatments, but they are costly or burdensome. Bottom line: High heterogeneity in response to treatment Within person (over time) and between person All require sequences of treatment decisions!

6 GENERATING HYPOTHEE vs BUILDING vs EVALUATING ADAPTIVE INTERVENTION

7 3 Different Research Questions/Aims = 3 Different Research Designs Aim 1: When generating hypotheses about an Adaptive Intervention: e.g., Does augmenting txt (as observed in a previous trial) for non-responders correlate with better outcomes? Aim 2: When building an Adaptive Intervention: e.g, What are the best tailoring variables and/or decision rules? Aim 3: When evaluating a particular Adaptive Intervention: e.g. Does the AI have a (statistically powered) clinically significant effect compared to suitable control?

8 3 Different Research Questions/Aims = 3 Different Research Designs Ex. Q1: Does augmenting txt for non-responders (as observed in a previous trial) correlate with better outcomes? Ex. Q2: What are the best tailoring variables or decision rules? Ex. Q3: Does an already-developed adaptive intervention have a statistically and clinically signif. effect as compared to control intervention? Observational tudies Experimental tudies Question Aim e.g., analysis of previous RCT e.g., MART e.g., RCT 1 Hypothesis Gen. YE 2 Building YE 3 Evaluating YE

9 EQUENTIAL MULTIPLE AIGNMENT RANDOMIZED TRIAL (MARTs) Multi-stage trials; same participants throughout Each stage is pre-fixed and corresponds to a critical decision point The goal of a MART is to inform the development of adaptive interventions.

10 Background for ADHD Treatment Example MART: Children Ages 6-12 Both medication (MED) and behavioral modification (BM) have been shown to be efficacious However, there is much debate on whether first-line intervention should be pharmacological or behavioral, especially in younger children Further, there is a need for a rescue treatment if the first treatment does not go well because 20-50% of children do not substantially improve on BM or MED o important questions for clinical practice include What treatment do we begin with: BM or MED? Among non-responders, what second treatment is best?

11 Concrete Example of a MART: Child ADHD PI: William Pelham, PhD, Florida International University, IE-Funded Grant N = 153, 8 month study, Monthly non-response (ITB < 75% and IR > 1 domain) R MED Responders Non-Responders R Continue: MED Intensify: Higher Dose MED Augment: MED + BM BM Responders Non-Responders R Continue: BM Intensify: Increase BM Augment: MED + BM

12 One of Four Adaptive Interventions Within the MART R MED Responders Non-Responders R Continue: MED Intensify: Higher Dose MED Augment: MED + BM BM Responders Non-Responders R Continue: BM Intensify: Increase BM Augment: MED + BM

13 4 Embedded Adaptive Interventions in this MART AI 2 AI 3 AI 4 AI 1 MED Non-Responders Intensify: Higher Dose MED Responders Continue MED MED Non-Responders Responders Augment: MED+BM Continue MED BM Non-Responders Responders Intensify: Increase BM Continue BM BM Non-Responders Augment: MED+BM Responders Continue BM

14 Background to adult obesity study with MART Design PI: Nancy herwood, PhD, HealthPartners and Univ. of MN, Minneapolis MN Rationale: (1) Response heterogeneity is observed in weight loss programs, with half of participants unable to achieve desired goals, a one size fits all approach is the norm, (2) non-response can be detected early. The primary aim is to evaluate the benefit of augmenting treatment with Meal Replacements (MR) versus switching to Acceptance Commitment Therapy (ACT) for non-responders. The secondary aim is to evaluate the optimal time to intervene with non-responders

15 Ongoing Adult Obesity tudy R * IBT for 3 weeks (N=250) A E R E P O N E IBT for 7 weeks (N=250) Responders Non-Responders A E R E P O N E R Responders Non-Responders Continue IBT Augment IBT: IBT + Meal Replacements witch from IBT: ACT R Continue IBT Augment IBT: IBT + Meal Replacements witch from IBT: ACT A B C D E F Baseline 5 Weeks 10 Weeks 20 Weeks * Participants and coaches are blind to group assignment until their randomly assigned response assessment time to reduce the impact of treatment assignment knowledge on early treatment performance

16 MART Designs MARTs are NOT Adaptive Experimental Designs (where, for example, a study is stopped if a treatment is ineffective or harmful) MART are fixed from the start Again, the goal of a MART is to inform the development of Adaptive Interventions

17 MART Design Principles 1. KI Principle: Keep It imple, traightforward 2. Power for simple important primary hypotheses 3. Take Appropriate steps to develop a more deeplyindividualized (optimized) Adaptive Intervention

18 KI Principle: Keep It imple, traightforward (Overarching Principle) At each stage, or critical decision point,... Restrict class of treatment options only by ethical, feasibility, or strong scientific considerations If you do restrict randomizations, use low dimensional summary to restrict subsequent treatments Use binary responder status hould be easy to use in actual clinical practice Collect additional, auxiliary time-varying measures To develop a more deeply-tailored Adaptive Intervention Think time-varying effect moderators

19 MART Design: Primary Aims Choose a simple primary aim/question that aids development of an adaptive intervention. tatistical methods used here aim to reduce uncertainty so the investigator can come away with a solid answer. ample size for the MART chosen based on the hypothesis test associated with this aim (e.g., use standard α = 5%).

20 MART Design: econdary Aims Choose secondary aims/questions that further develop the Adaptive Intervention and take advantage of sequential randomization to eliminate confounding. tatistical methods used here aim to generate hypotheses, e.g., generate good hypotheses about additional tailoring variables or moderators. Here, investigators will tolerate hypothesis tests with higher Type-I error, e.g., α = 10%.

21 Final Comments Adaptive Interventions individualize treatment up-front and throughout; they are guides for clinical practice MARTs are not Adaptive Trial Designs, but are used to build better Adaptive Interventions (ubsequent study: RCT of MART-optimized Adaptive Intervention vs control) MARTs do not have to be complicated; MARTs do not necessarily require larger sample sizes

22 Additional recommended reference H. Lei, I. Nahum-hani, K. Lynch, D. Oslin, 5and.A. Murphy A MART Design for Building Individualized Treatment equences, Annu. Rev. Clin. Psychol :

Introduction to Adaptive Interventions and SMART Study Design Principles

Introduction to Adaptive Interventions and SMART Study Design Principles Introduction to Adaptive Interventions and SMAT Study Design Principles Daniel Almirall 1,2 Linda M Collins 2,3,5 Susan A Murphy 1,2,4 1 Institute for Social esearch, University of Michigan 2 The Methodology

More information

Developing Adaptive Health Interventions

Developing Adaptive Health Interventions Developing Adaptive Health Interventions Getting SMART Daniel Almirall 1,2 Susan A Murphy 1,2,3 1 Institute for Social Research, Survey Research Center, University of Michigan 2 The Methodology Center,

More information

DISCUSSION OPTIMIZING BEHAVIORAL INTERVENTIONS TO ADVANCE THE NATIONAL HIV/AIDS STRATEGY

DISCUSSION OPTIMIZING BEHAVIORAL INTERVENTIONS TO ADVANCE THE NATIONAL HIV/AIDS STRATEGY DISCUSSION OPTIMIZING BEHAVIORAL INTERVENTIONS TO ADVANCE THE NATIONAL HIV/AIDS STRATEGY Daniel Almirall The Methodology Center Univ of Michigan, Survey Research Center, ISR Presented at The Future of

More information

SMART Clinical Trial Designs for Dynamic Treatment Regimes

SMART Clinical Trial Designs for Dynamic Treatment Regimes SMART Clinical Trial Designs for Dynamic Treatment Regimes Bibhas Chakraborty Centre for Quantitative Medicine, Duke-NUS Graduate Medical School, Singapore bibhas.chakraborty@duke-nus.edu.sg MCP Conference

More information

Getting SMART about Adapting Interventions. S.A. Murphy Early Childhood Interventions Inaugural Conference 04/21/12

Getting SMART about Adapting Interventions. S.A. Murphy Early Childhood Interventions Inaugural Conference 04/21/12 Getting SMART about Adapting Interventions S.A. Murphy Early Childhood Interventions Inaugural Conference 04/21/12 Adaptive Interventions are individually tailored sequences of interventions, with treatment

More information

Sequential, Multiple Assignment, Randomized Trials

Sequential, Multiple Assignment, Randomized Trials Sequential, Multiple Assignment, Randomized Trials Module 2 Experimental Design and Analysis Methods for Developing Adaptive Interventions: Getting SMART Daniel Almirall, Ahnalee Brincks, Billie Nahum-Shani

More information

On Adaptive Interventions and SMART

On Adaptive Interventions and SMART On Adaptive Interventions and SMART Daniel Almirall; Inbal (Billie) Nahum- Shani; Shawna Smith School of Nursing University of Michigan February 3, 2016 1 Outline Adaptive Intervention (AIs) What are AIs?

More information

50 min. SMART Study Designs for Developing Adaptive Interventions. SA Murphy 1

50 min. SMART Study Designs for Developing Adaptive Interventions. SA Murphy 1 50 min. SMART Study Designs for Developing Adaptive Interventions SA Murphy 1 Other names are dynamic treatment regimes, treatment algorithms, stepped care models, expert systems, adaptive treatment strategy,

More information

BIOSTATISTICAL METHODS

BIOSTATISTICAL METHODS BIOSTATISTICAL METHODS FOR TRANSLATIONAL & CLINICAL RESEARCH ADAPTIVE DESIGN: SMART TRIALS ADAPTIVE CLINICAL TRIALS An adaptive clinical trial is a clinical trial that evaluates a treatment (or treatments)

More information

60 minutes Give examples of SMARTs that are completed or in the field o ASD, child ADHD, women who are pregnant and abuse substances, adult alcohol

60 minutes Give examples of SMARTs that are completed or in the field o ASD, child ADHD, women who are pregnant and abuse substances, adult alcohol 60 minutes Give examples of SMARTs that are completed or in the field o ASD, child ADHD, women who are pregnant and abuse substances, adult alcohol use, depression Discuss the variety of rationales underlying

More information

W H E R E D O W E G O F R O M H E R E? N E X T G E N E R AT I O N T R E AT M E N T I N T E R V E N T I O N S R AY N I A U R A, P H D

W H E R E D O W E G O F R O M H E R E? N E X T G E N E R AT I O N T R E AT M E N T I N T E R V E N T I O N S R AY N I A U R A, P H D W H E R E D O W E G O F R O M H E R E? N E X T G E N E R AT I O N T R E AT M E N T I N T E R V E N T I O N S R AY N I A U R A, P H D Outline Personalized treatment & personalized medicine Clinical algorithms

More information

40 min. SMART Study Designs for Developing Adaptive Interventions. SA Murphy 1

40 min. SMART Study Designs for Developing Adaptive Interventions. SA Murphy 1 40 min. SMART Study Designs for Developing Adaptive Interventions SA Murphy 1 Other names are dynamic treatment regimes, treatment algorithms, stepped care models, expert systems, adaptive treatment strategy,

More information

Adaptive Interventions: What are they? Why do we need them? and How can we study them?

Adaptive Interventions: What are they? Why do we need them? and How can we study them? Adaptive Interventions: What are they? Why do we need them? and How can we study them? Daniel Almirall, Inbal Nahum-Shani, Susan A. Murphy Survey Research Center, Institute for Social Research University

More information

SMARTs in Practice: Case Studies in Design and Analysis. Marie Davidian and Eric B. Laber

SMARTs in Practice: Case Studies in Design and Analysis. Marie Davidian and Eric B. Laber SMARTs in Practice: Case Studies in Design and Analysis Marie Davidian and Eric B. Laber Department of Statistics North Carolina State University 2017 Duke Industry Statistics Symposium September 7, 2017

More information

Lecture 1: Introduction to Personalized Medicine. Donglin Zeng, Department of Biostatistics, University of North Carolina

Lecture 1: Introduction to Personalized Medicine. Donglin Zeng, Department of Biostatistics, University of North Carolina Lecture 1: Introduction to Personalized Medicine Personalized Medicine A Quick View Personalized Medicine is a general medical paradigm referring to systematic use of individual patient information to

More information

Optimization of behavioral dynamic treatment regimens based on the sequential, multiple assignment, randomized trial (SMART)

Optimization of behavioral dynamic treatment regimens based on the sequential, multiple assignment, randomized trial (SMART) CLINICAL TRIALS ARTICLE Clinical Trials 2014; 11: 426 434 Optimization of behavioral dynamic treatment regimens based on the sequential, multiple assignment, randomized trial (SMART) Linda M Collins a,

More information

60 minutes. This is the 4 th module of a 6 module Seminar on experimental designs for building optimal adaptive health interventions.

60 minutes. This is the 4 th module of a 6 module Seminar on experimental designs for building optimal adaptive health interventions. 60 minutes This is the 4 th module of a 6 module Seminar on experimental designs for building optimal adaptive health interventions. By now, you know what an ATS is. You have discussed why they are important

More information

A SMART Design for Building Individualized Treatment Sequences

A SMART Design for Building Individualized Treatment Sequences I E V I E W S N A D V A N E C A SMAT Design for Building Individualized Treatment Sequences H. Lei, 1 I. Nahum-Shani, 2 K. Lynch, 3 D. Oslin, 4 and S.A. Murphy 5 1 Department of Statistics, University

More information

An Adaptive Intervention for Reducing College Student Alcohol RltdC Related Consequences: A SMART Pilot Study Proposal

An Adaptive Intervention for Reducing College Student Alcohol RltdC Related Consequences: A SMART Pilot Study Proposal An Adaptive Intervention for Reducing College Student Alcohol RltdC Related Consequences: A SMART Pilot Study Proposal Megan Patrick & Daniel Almirall SRC, ISR, University of Michigan Center for the Study

More information

Designing a Pilot Sequential Multiple Assignment Randomized Trial for Developing an Adaptive Treatment Strategy

Designing a Pilot Sequential Multiple Assignment Randomized Trial for Developing an Adaptive Treatment Strategy Designing a Pilot Sequential Multiple Assignment Randomized Trial for Developing an Adaptive Treatment Strategy Daniel Almirall, Scott N. Compton, Meredith Gunlicks-Stoessel, Naihua Duan & Susan A. Murphy

More information

Lecture 5: Sequential Multiple Assignment Randomized Trials (SMARTs) for DTR. Donglin Zeng, Department of Biostatistics, University of North Carolina

Lecture 5: Sequential Multiple Assignment Randomized Trials (SMARTs) for DTR. Donglin Zeng, Department of Biostatistics, University of North Carolina Lecture 5: Sequential Multiple Assignment Randomized Trials (SMARTs) for DTR Introduction Introduction Consider simple DTRs: D = (D 1,..., D K ) D k (H k ) = 1 or 1 (A k = { 1, 1}). That is, a fixed treatment

More information

mhealth Technologies

mhealth Technologies Micro-randomized Trial Designs for Research Using JITAIs mhealth Technologies HeartSteps JITAI JITAIs S.A. Murphy CTN, Webinar JITAIs Outline Just-in-Time Adaptive Interventions MD2K Smoking Cessation

More information

Automatic learning of adaptive treatment strategies. using kernel-based reinforcement learning

Automatic learning of adaptive treatment strategies. using kernel-based reinforcement learning using kernel-based reinforcement learning Presented by:, School of Computer Science, McGill University Joint work with: Marc G. Bellemare, Adrian Ghizaru, Zaid Zawaideh, Susan Murphy (Univ. Michigan),

More information

Version No. 7 Date: July Please send comments or suggestions on this glossary to

Version No. 7 Date: July Please send comments or suggestions on this glossary to Impact Evaluation Glossary Version No. 7 Date: July 2012 Please send comments or suggestions on this glossary to 3ie@3ieimpact.org. Recommended citation: 3ie (2012) 3ie impact evaluation glossary. International

More information

Clinical Trials. Susan G. Fisher, Ph.D. Dept. of Clinical Sciences

Clinical Trials. Susan G. Fisher, Ph.D. Dept. of Clinical Sciences Clinical Trials Susan G. Fisher, Ph.D. Dept. of Clinical Sciences When to Do a RCT Exposure of interest is modifiable and individuals are willing to relinquish control Legitimate uncertainty exists about

More information

Evaluating Social Programs Course: Evaluation Glossary (Sources: 3ie and The World Bank)

Evaluating Social Programs Course: Evaluation Glossary (Sources: 3ie and The World Bank) Evaluating Social Programs Course: Evaluation Glossary (Sources: 3ie and The World Bank) Attribution The extent to which the observed change in outcome is the result of the intervention, having allowed

More information

Summary of guideline for the. treatment of depression RANZCP CLINICAL PRACTICE GUIDELINES ASSESSMENT

Summary of guideline for the. treatment of depression RANZCP CLINICAL PRACTICE GUIDELINES ASSESSMENT RANZCP CLINICAL PRACTICE GUIDELINES Summary of guideline for the RANZCP CLINICAL PRACTICE GUIDELINES treatment of depression Pete M. Ellis, Ian B. Hickie and Don A. R. Smith for the RANZCP Clinical Practice

More information

An Introduction to Dynamic Treatment Regimes

An Introduction to Dynamic Treatment Regimes An Introduction to Dynamic Treatment Regimes Marie Davidian Department of Statistics North Carolina State University http://www4.stat.ncsu.edu/davidian 1/64 Dynamic Treatment Regimes Webinar Outline What

More information

115 remained abstinent. 140 remained abstinent. Relapsed Remained abstinent Total

115 remained abstinent. 140 remained abstinent. Relapsed Remained abstinent Total Chapter 10 Exercises 1. Intent-to-treat analysis: Example 1 In a randomized controlled trial to determine whether the nicotine patch reduces the risk of relapse among smokers who have committed to quit,

More information

Comparing Dynamic Treatment Regimes Using Repeated-Measures Outcomes: Modeling Considerations in SMART Studies

Comparing Dynamic Treatment Regimes Using Repeated-Measures Outcomes: Modeling Considerations in SMART Studies Comparing Dynamic Treatment Regimes Using Repeated-Measures Outcomes: Modeling Considerations in SMART Studies Xi Lu The University of Michigan Connie Kasari University of California Los Angeles Inbal

More information

recommendations should I care?

recommendations should I care? recommendations should I care? Background Grading of Recommendations, Assessment, Development and Evaluation (GRADE) is a widely used rating system Several COG-endorsed supportive care guidelines have

More information

Surveillance report Published: 13 April 2017 nice.org.uk. NICE All rights reserved.

Surveillance report Published: 13 April 2017 nice.org.uk. NICE All rights reserved. Surveillance report 2017 Antisocial behaviour and conduct disorders in children and young people: recognition and management (2013) NICE guideline CG158 Surveillance report Published: 13 April 2017 nice.org.uk

More information

CONSORT 2010 checklist of information to include when reporting a randomised trial*

CONSORT 2010 checklist of information to include when reporting a randomised trial* CONSORT 2010 checklist of information to include when reporting a randomised trial* Section/Topic Title and abstract Introduction Background and objectives Item No Checklist item 1a Identification as a

More information

Challenges in Developing Learning Algorithms to Personalize mhealth Treatments

Challenges in Developing Learning Algorithms to Personalize mhealth Treatments Challenges in Developing Learning Algorithms to Personalize mhealth Treatments JOOLHEALTH Bar-Fit Susan A Murphy 01.16.18 HeartSteps SARA Sense 2 Stop Continually Learning Mobile Health Intervention 1)

More information

The comparison or control group may be allocated a placebo intervention, an alternative real intervention or no intervention at all.

The comparison or control group may be allocated a placebo intervention, an alternative real intervention or no intervention at all. 1. RANDOMISED CONTROLLED TRIALS (Treatment studies) (Relevant JAMA User s Guides, Numbers IIA & B: references (3,4) Introduction: The most valid study design for assessing the effectiveness (both the benefits

More information

Interventions for Autism: Translating Research into Practice

Interventions for Autism: Translating Research into Practice Interventions for Autism: Translating Research into Practice Cindy Canceko Llego, MD, MSc Developmental-Behavioral Pediatrician Clinical Epidemiologist Objectives To discuss the importance of good scientific

More information

In this second module in the clinical trials series, we will focus on design considerations for Phase III clinical trials. Phase III clinical trials

In this second module in the clinical trials series, we will focus on design considerations for Phase III clinical trials. Phase III clinical trials In this second module in the clinical trials series, we will focus on design considerations for Phase III clinical trials. Phase III clinical trials are comparative, large scale studies that typically

More information

A Framework for Patient-Centered Outcomes Research

A Framework for Patient-Centered Outcomes Research A Framework for Patient-Centered Outcomes Research David H. Hickam, MD, MPH Director of Research Methodology, PCORI Baltimore, MD August 9, 2016 Session Faculty Disclosures David H. Hickam, MD, MPH No

More information

Power & Sample Size. Dr. Andrea Benedetti

Power & Sample Size. Dr. Andrea Benedetti Power & Sample Size Dr. Andrea Benedetti Plan Review of hypothesis testing Power and sample size Basic concepts Formulae for common study designs Using the software When should you think about power &

More information

Common Criteria. for. CGIAR Research Proposal (CRP) Design and Assessment

Common Criteria. for. CGIAR Research Proposal (CRP) Design and Assessment Common Criteria for CGIAR Research Proposal (CRP) Design and Assessment 30 August 2010 1 CGIAR Research Proposals (CRPs) are reviewed at various stages of their development and approval. These assessments

More information

Evaluating Survey Data: Mediation Analysis and Propensity Score Matching

Evaluating Survey Data: Mediation Analysis and Propensity Score Matching Evaluating Survey Data: Mediation Analysis and Propensity Score Matching Emily Ricotta, ScM Senior Research Assistant Johns Hopkins Center for Communication Programs Outline Mediation Analysis What is

More information

Getting SMART about Combating Autism with Adaptive Interventions: Novel Treatment and Research Methods

Getting SMART about Combating Autism with Adaptive Interventions: Novel Treatment and Research Methods Getting SMART about Combating Autism with Adaptive Interventions: Novel Treatment and Research Methods 1. Introduction to Sequential Multiple Assignment Randomized Trials and Adaptive Interventions: Two

More information

Implementing the ASSIST smoking prevention programme following a successful RCT. Rona Campbell

Implementing the ASSIST smoking prevention programme following a successful RCT. Rona Campbell Implementing the ASSIST smoking prevention programme following a successful RCT Rona Campbell DECIPHer Development and Evaluation of Complex Interventions for Public Health Improvement Aim Review issues

More information

Translational Science in the Behavioral Domain: More interventions please... but enough with the efficacy! Paul A. Estabrooks, PhD

Translational Science in the Behavioral Domain: More interventions please... but enough with the efficacy! Paul A. Estabrooks, PhD Translational Science in the Behavioral Domain: More interventions please... but enough with the efficacy! Paul A. Estabrooks, PhD Disclosures Financial: Carilion Clinic Scientific Biases: Efficacy trials

More information

Study Design STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL STUDY DESIGN

Study Design STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL STUDY DESIGN STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL Daniel E. Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine Introduction to Clinical Research July 15, 2014 STUDY DESIGN Provides

More information

RATING OF A RESEARCH PAPER. By: Neti Juniarti, S.Kp., M.Kes., MNurs

RATING OF A RESEARCH PAPER. By: Neti Juniarti, S.Kp., M.Kes., MNurs RATING OF A RESEARCH PAPER RANDOMISED CONTROLLED TRIAL TO COMPARE SURGICAL STABILISATION OF THE LUMBAR SPINE WITH AN INTENSIVE REHABILITATION PROGRAMME FOR PATIENTS WITH CHRONIC LOW BACK PAIN: THE MRC

More information

A micropower support vector machine based seizure detection architecture for embedded medical devices

A micropower support vector machine based seizure detection architecture for embedded medical devices A micropower support vector machine based seizure detection architecture for embedded medical devices The MIT Faculty has made this article openly available. Please share how this access benefits you.

More information

Citation for published version (APA): Weert, E. V. (2007). Cancer rehabilitation: effects and mechanisms s.n.

Citation for published version (APA): Weert, E. V. (2007). Cancer rehabilitation: effects and mechanisms s.n. University of Groningen Cancer rehabilitation Weert, Ellen van IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document

More information

Statistical Power Sampling Design and sample Size Determination

Statistical Power Sampling Design and sample Size Determination Statistical Power Sampling Design and sample Size Determination Deo-Gracias HOUNDOLO Impact Evaluation Specialist dhoundolo@3ieimpact.org Outline 1. Sampling basics 2. What do evaluators do? 3. Statistical

More information

Copyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD

Copyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD ASSISTANT PROFESSOR DEPARTMENT OF CLINICAL EPIDEMIOLOGY AND BIOSTATISTICS, MCMASTER UNIVERSITY Nancy Santesso,

More information

June 9, Michael L. LeFevre, M.D., M.S.P.H. Chair, United States Preventive Services Task Force 540 Gaither Road Rockville, MD 20850

June 9, Michael L. LeFevre, M.D., M.S.P.H. Chair, United States Preventive Services Task Force 540 Gaither Road Rockville, MD 20850 June 9, 2014 Michael L. LeFevre, M.D., M.S.P.H. Chair, United States Preventive Services Task Force 540 Gaither Road Rockville, MD 20850 Re: Draft Recommendation Statement: Behavioral Counseling to Promote

More information

New Mexico TEAM Professional Development Module: Autism

New Mexico TEAM Professional Development Module: Autism [Slide 1]: Welcome Welcome to the New Mexico TEAM technical assistance module on making eligibility determinations under the category of autism. This module will review the guidance of the NM TEAM section

More information

TOPICS TO BE EVALUATED BEFORE THE FORMAL OBSERVATION. Outcome: Make Ethical Decisions. Outcome: Provide Support to Athletes in Training

TOPICS TO BE EVALUATED BEFORE THE FORMAL OBSERVATION. Outcome: Make Ethical Decisions. Outcome: Provide Support to Athletes in Training Archery Canada - Practice Evaluation Tool NCCP Competition Development Name: Evaluator: CC#: Date: Evaluator signature: Scoring for : The evaluator should assign a Y (yes) or N (no) for each evidence found.

More information

Description of intervention

Description of intervention Helping to Overcome PTSD through Empowerment (HOPE) Johnson, D., Zlotnick, C. and Perez, S. (2011) Johnson, D. M., Johnson, N. L., Perez, S. K., Palmieri, P. A., & Zlotnick, C. (2016) Description of Helping

More information

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES

MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) Medicines Management Services aim to ensure that (i) Service users receive their medicines

More information

Antiretroviral therapy for adults and adolescents KEY MESSAGES. HIV/AIDS Department BACKGROUND

Antiretroviral therapy for adults and adolescents KEY MESSAGES. HIV/AIDS Department BACKGROUND KEY MESSAGES New WHO Recommendations: Antiretroviral therapy for adults and adolescents The World Health Organization (WHO) is revising its guidelines on antiretroviral therapy (ART) for adults and adolescents.

More information

Overview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools: Opportunities and Challenges of Application in Developing DRIs

Overview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools: Opportunities and Challenges of Application in Developing DRIs Workshop on Guiding Principles for the Inclusion of Chronic Diseases Endpoints in Future Dietary Reference Intakes (DRIs) Overview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools:

More information

Accelerating Patient-Centered Outcomes Research and Methodological Research

Accelerating Patient-Centered Outcomes Research and Methodological Research Accelerating Patient-Centered Outcomes Research and Methodological Research Jason Gerson, PhD CER Methods JSM 2016 July 31, 2016 In This Session PCORI Overview Methods Program Overview Methods Program

More information

Treatment Algorithm Treatment Algorithm

Treatment Algorithm Treatment Algorithm Treatment Algorithm Treatment Algorithm Primary Care Toolkit September 2015 Page 2 Adult (>18 years) Depression Flow Chart (Generic) Two Question Screen: PHQ-2 Annually, new adult patients, and when suspect

More information

DRAFT (Final) Concept Paper On choosing appropriate estimands and defining sensitivity analyses in confirmatory clinical trials

DRAFT (Final) Concept Paper On choosing appropriate estimands and defining sensitivity analyses in confirmatory clinical trials DRAFT (Final) Concept Paper On choosing appropriate estimands and defining sensitivity analyses in confirmatory clinical trials EFSPI Comments Page General Priority (H/M/L) Comment The concept to develop

More information

COMBINING SINGLE CASE DESIGN AND GROUP EXPERIMENTAL DESIGN RESEARCH

COMBINING SINGLE CASE DESIGN AND GROUP EXPERIMENTAL DESIGN RESEARCH COMBINING SINGLE CASE DESIGN AND GROUP EXPERIMENTAL DESIGN RESEARCH Ann P. Kaiser, PhD Vanderbilt University IES SCD June 2018 1 Today s Talk Overview of research on Enhanced Milieu Teaching (EMT) Illustrate

More information

Presented at the Research Methodology Center Ohio State University September 29, 2016

Presented at the Research Methodology Center Ohio State University September 29, 2016 The Multiphase Optimization Strategy (MOST) for developing more effective, efficient, economical, and scalable behavioral and biobehavioral interventions Linda M. Collins The Methodology Center and Department

More information

New Mexico TEAM Professional Development Module: Deaf-blindness

New Mexico TEAM Professional Development Module: Deaf-blindness [Slide 1] Welcome Welcome to the New Mexico TEAM technical assistance module on making eligibility determinations under the category of deaf-blindness. This module will review the guidance of the NM TEAM

More information

Practical Interventions for Co-occurring Disorders: Dissemination from Efficacy and Effectiveness Studies

Practical Interventions for Co-occurring Disorders: Dissemination from Efficacy and Effectiveness Studies Practical Interventions for Co-occurring Disorders: Dissemination from Efficacy and Effectiveness Studies Sitharthan Thiagarajan *Australian Centre for Addiction Research www.acar.net.au Today s presentation

More information

04/12/2014. Research Methods in Psychology. Chapter 6: Independent Groups Designs. What is your ideas? Testing

04/12/2014. Research Methods in Psychology. Chapter 6: Independent Groups Designs. What is your ideas? Testing Research Methods in Psychology Chapter 6: Independent Groups Designs 1 Why Psychologists Conduct Experiments? What is your ideas? 2 Why Psychologists Conduct Experiments? Testing Hypotheses derived from

More information

CDEC FINAL RECOMMENDATION

CDEC FINAL RECOMMENDATION CDEC FINAL RECOMMENDATION ARIPIPRAZOLE LONG-ACTING INJECTION (Abilify Maintena Otsuka Pharmaceuticals Co. & Lundbeck Canada Inc.) Indication: Schizophrenia Recommendation: The Canadian Drug Expert Committee

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA) Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology

More information

NIH Public Access Author Manuscript J Am Stat Assoc. Author manuscript.

NIH Public Access Author Manuscript J Am Stat Assoc. Author manuscript. NIH Public Access Author Manuscript SMART Design Issues and the Consideration of Opposing Outcomes: Discussion of Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced

More information

Overview of Study Designs

Overview of Study Designs Overview of Study Designs Kyoungmi Kim, Ph.D. July 13 & 20, 2016 This seminar is jointly supported by the following NIH-funded centers: We are video recording this seminar so please hold questions until

More information

Exploring Network Effects and Tobacco Use with SIENA

Exploring Network Effects and Tobacco Use with SIENA Exploring Network Effects and Tobacco Use with IENA David R. chaefer chool of Human Evolution & ocial Change Arizona tate University upported by the National Institutes of Health (R21-HD060927, R21HD071885)

More information

SWITCH Trial. A Sequential Multiple Adaptive Randomization Trial

SWITCH Trial. A Sequential Multiple Adaptive Randomization Trial SWITCH Trial A Sequential Multiple Adaptive Randomization Trial Background Cigarette Smoking (CDC Estimates) Morbidity Smoking caused diseases >16 million Americans (1 in 30) Mortality 480,000 deaths per

More information

Adaptive designs: When are they sensible?

Adaptive designs: When are they sensible? Adaptive designs: When are they sensible? Janet Wittes Statistics Collaborative, Inc. Sensible Guidelines May 2012 The pitch Clinical trials are too rigid There are new classes of designs More ethical

More information

Research Methodology Workshop. Study Type

Research Methodology Workshop. Study Type Research Methodology Workshop Study Type What type of question? Frequency: how common is it? Aetiology: What caused this? Intervention: Does this intervention work? Diagnosis or test evaluation: How accurate

More information

Royal College of Psychiatrists in Wales Consultation Response

Royal College of Psychiatrists in Wales Consultation Response Royal College of Psychiatrists in Wales Consultation Response RESPONSE OF: RESPONSE TO: THE ROYAL COLLEGE OF PSYCHIATRISTS in WALES The Autism Bill Date: 20 November 2017 The Royal College of Psychiatrists

More information

American Board of Naturopathic Oncology 2014 Exam Application

American Board of Naturopathic Oncology 2014 Exam Application American Board of Naturopathic Oncology 2014 Exam Application SECTION 1. General Information Name Address City, State, Zip Telephone Email SECTION 2. Education and Licensing CNME Accredited Naturopathic

More information

PO Box 19015, Arlington, TX {ramirez, 5323 Harry Hines Boulevard, Dallas, TX

PO Box 19015, Arlington, TX {ramirez, 5323 Harry Hines Boulevard, Dallas, TX From: Proceedings of the Eleventh International FLAIRS Conference. Copyright 1998, AAAI (www.aaai.org). All rights reserved. A Sequence Building Approach to Pattern Discovery in Medical Data Jorge C. G.

More information

Counselling Should: Recognize that behaviour change is difficult and human beings are not perfect

Counselling Should: Recognize that behaviour change is difficult and human beings are not perfect Counselling Should: Be sensitive, inclusive, and non-judgmental Recognize that behaviour change is difficult and human beings are not perfect Be presented as a personal choice Counselling should support

More information

Performance of Initiating Q South London and Maudsley NHS Foundation Trust:

Performance of Initiating Q South London and Maudsley NHS Foundation Trust: Research Ethics Committee Reference Number Integrated Research Application System Number Submission Type Name of Trial Date of Receipt of Valid Research Application Date of NHS First Patient Recruited?

More information

4/10/2018. Choosing a study design to answer a specific research question. Importance of study design. Types of study design. Types of study design

4/10/2018. Choosing a study design to answer a specific research question. Importance of study design. Types of study design. Types of study design Choosing a study design to answer a specific research question Importance of study design Will determine how you collect, analyse and interpret your data Helps you decide what resources you need Impact

More information

Authors face many challenges when summarising results in reviews.

Authors face many challenges when summarising results in reviews. Describing results Authors face many challenges when summarising results in reviews. This document aims to help authors to develop clear, consistent messages about the effects of interventions in reviews,

More information

Depression & Diabetes: Pathways and TeamCare Studies

Depression & Diabetes: Pathways and TeamCare Studies Depression & Diabetes: Pathways and TeamCare Studies Wayne Katon, MD 1 Mike VonKorff, ScD 2 Elizabeth Lin, MD, MPH 2 Paul Ciechanowski, MD, MPH 1 Evette Ludman, PhD 2 Joan Russo, PhD 1 Carolyn Rutter,

More information

Single Technology Appraisal (STA) Tildrakizumab for treating moderate to severe plaque psoriasis

Single Technology Appraisal (STA) Tildrakizumab for treating moderate to severe plaque psoriasis Single Technology Appraisal (STA) Tildrakizumab for treating moderate to severe plaque psoriasis Response to consultee and commentator comments on the draft remit and draft scope (pre-referral) Please

More information

Just-In-Time Adaptive Interventions: Scientific Motivation and Key Components

Just-In-Time Adaptive Interventions: Scientific Motivation and Key Components Just-In-Time Adaptive Interventions: Scientific Motivation and Key Components Institute for Translational Research in Children s Mental Health Oct 2016 Inbal (Billie) Nahum-Shani Institute for Social Research

More information

EXPERIMENTAL DESIGN Page 1 of 11. relationships between certain events in the environment and the occurrence of particular

EXPERIMENTAL DESIGN Page 1 of 11. relationships between certain events in the environment and the occurrence of particular EXPERIMENTAL DESIGN Page 1 of 11 I. Introduction to Experimentation 1. The experiment is the primary means by which we are able to establish cause-effect relationships between certain events in the environment

More information

CRITICALLY APPRAISED PAPER (CAP)

CRITICALLY APPRAISED PAPER (CAP) CRITICALLY APPRAISED PAPER (CAP) FOCUSED QUESTION Does occupational therapy with sensory integration (OT-SI) better improve attention, cognitive and social, sensory, or behavioral problems than an activity

More information

UNIVERSITY OF WASHINGTON PSYCHIATRY RESIDENCY PROGRAM COGNITIVE-BEHAVIORAL THERAPY (CBT) COMPETENCIES

UNIVERSITY OF WASHINGTON PSYCHIATRY RESIDENCY PROGRAM COGNITIVE-BEHAVIORAL THERAPY (CBT) COMPETENCIES UNIVERSITY OF WASHINGTON PSYCHIATRY RESIDENCY PROGRAM COGNITIVE-BEHAVIORAL THERAPY (CBT) COMPETENCIES Knowledge The resident will demonstrate: The ability to articulate the key principles related to cognitive-behavioral

More information

Considerations in Optimizing Personalized Treatments: Estimation and Evaluation in Light of Benefit and Risk

Considerations in Optimizing Personalized Treatments: Estimation and Evaluation in Light of Benefit and Risk Considerations in Optimizing Personalized Treatments: Estimation and Evaluation in Light of Benefit and Risk Yuanjia Wang, Ph.D. Department of Biostatistics, Mailman School of Public Health & Division

More information

Epidemiologic Methods and Counting Infections: The Basics of Surveillance

Epidemiologic Methods and Counting Infections: The Basics of Surveillance Epidemiologic Methods and Counting Infections: The Basics of Surveillance Ebbing Lautenbach, MD, MPH, MSCE University of Pennsylvania School of Medicine Nothing to disclose PENN Outline Definitions / Historical

More information

Discovering Evidence-Based Practice: What Does Research Tell Us? John D. Molteni, Ph.D. BCBA-D Saint Joseph College

Discovering Evidence-Based Practice: What Does Research Tell Us? John D. Molteni, Ph.D. BCBA-D Saint Joseph College Discovering Evidence-Based Practice: What Does Research Tell Us? John D. Molteni, Ph.D. BCBA-D Saint Joseph College Outline for Today Discuss how one should read and understand research Discuss how one

More information

Introduzione al metodo GRADE

Introduzione al metodo GRADE Introduzione al metodo GRADE Atto Billio MD, MSc EBHC Ematologia e TMO-Bolzano Gruppo linee guida SIE Critique of EBM De-emphasizes patient values Doesn t account for individual variation Devalues clinical

More information

CRITICAL APPRAISAL SKILLS PROGRAMME Making sense of evidence about clinical effectiveness. 11 questions to help you make sense of case control study

CRITICAL APPRAISAL SKILLS PROGRAMME Making sense of evidence about clinical effectiveness. 11 questions to help you make sense of case control study CRITICAL APPRAISAL SKILLS PROGRAMME Making sense of evidence about clinical effectiveness 11 questions to help you make sense of case control study General comments Three broad issues need to be considered

More information

Building a learning healthcare system for suicide prevention

Building a learning healthcare system for suicide prevention Building a learning healthcare system for suicide prevention Gregory Simon MD MPH Kaiser Permanente Washington Health Research Institute Mental Health Research Network Depression and Bipolar Support Alliance

More information

The RoB 2.0 tool (individually randomized, cross-over trials)

The RoB 2.0 tool (individually randomized, cross-over trials) The RoB 2.0 tool (individually randomized, cross-over trials) Study design Randomized parallel group trial Cluster-randomized trial Randomized cross-over or other matched design Specify which outcome is

More information

Building an evidence-based social sector in New Zealand. Prepared and presented by Dr Carolyn O Fallon September 2017

Building an evidence-based social sector in New Zealand. Prepared and presented by Dr Carolyn O Fallon September 2017 Building an evidence-based social sector in New Zealand Prepared and presented by Dr Carolyn O Fallon September 2017 Today Setting the scene: Social investment approach Budget 2017 process Assessing evidence

More information

Physical Activity: Family-Based Interventions

Physical Activity: Family-Based Interventions Physical Activity: Family-Based Interventions Community Preventive Services Task Force Finding and Rationale Statement Ratified October 2016 Table of Contents Context... 2 Intervention Definition... 2

More information

Illness Management & Recovery (IMR) Results of a pilot, Design of an RCT, Challenges

Illness Management & Recovery (IMR) Results of a pilot, Design of an RCT, Challenges Illness Management & Recovery (IMR) Results of a pilot, Design of an RCT, Challenges Bert-Jan Roosenschoon, psychologist, senior-researcher, Parnassia Academy, Rotterdam the Netherlands ESPRi, november

More information

Study Designs in Epidemiology

Study Designs in Epidemiology Study Designs in Epidemiology Dr. Sireen Alkhaldi, BDS, MPH, DrPH First semester 2017/ 2018 Department of Family and Community Medicine School of Medicine/ The University of Jordan Epidemiologic Study

More information

Recommended Component: Assure Immediate Access to Medications as Prescribed

Recommended Component: Assure Immediate Access to Medications as Prescribed Recommended Component: Assure Immediate Access to Medications as Prescribed Students must have immediate access to all medications as approved by healthcare providers and parents, regardless of the availability

More information

Applying STPA to the Artificial Pancreas for People with Type 1 Diabetes

Applying STPA to the Artificial Pancreas for People with Type 1 Diabetes Applying STPA to the Artificial Pancreas for People with Type 1 Diabetes Lane Desborough Product Strategist Medtronic Diabetes Northridge, California Type 1 Diabetes Artificial Pancreas Challenges Applying

More information